Why should I choose China for SAVR?

China offers SAVR at approximately $19,000—roughly 60–70% less than in the U.S. or Western Europe—without compromising quality. Leading cardiology centers in Beijing, Shanghai, and Guangzhou use the same FDA-approved mechanical and biological valves from global manufacturers like Edwards Lifesciences or Medtronic. Chinese surgeons perform high volumes (often 200+ SAVR cases annually per surgeon), which correlates with better outcomes and fewer complications. Additionally, hospitals provide comprehensive packages including pre-op testing, surgery, accommodation, and follow-up, with English-speaking coordinators to manage your care.